All Episodes

June 27, 2018 15 mins

Dave Domzalski, CEO, Foamix Pharmaceuticals reminds us that acne is the most common skin condition affecting 50 million people in the US alone, how little has changed in the treatment of outbreaks, and how side effects of commonly prescribed acne treatments often result in many people discontinuing use leaving their acne unresolved.  Foamix is in late stage development of a topical form of minocycline, usually prescribed as an oral antibiotic, that is applied directly to the skin as a foam and that is showing fewer side-effects and greater impact.

#acne #acneprone #AcneAwareness #skincare #clearskin #dermatology #dermatologist

 Foamix Pharmaceuticals

Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC
Death, Sex & Money

Death, Sex & Money

Anna Sale explores the big questions and hard choices that are often left out of polite conversation.

Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.